//
The Hospital Readmissions Reduction Program Nationwide Perspectives and Recommendations: A JACC: Heart Failure Position Paper
Effect of empagliflozin on exercise ability and symptoms in heart failure patients with reduced and preserved ejection fraction, with and without type 2 diabetes
Mechanical circulatory support devices for acute right ventricular failure
Effects of Liraglutide on Cardiovascular Outcomes in Patients With Diabetes With or Without Heart Failure
Reduced Apolipoprotein M and Adverse Outcomes Across the Spectrum of Human Heart Failure
Randomized Evaluation of Heart Failure With Preserved Ejection Fraction Patients With Acute Heart Failure and Dopamine - The ROPA-DOP Trial
Proteomics to Improve Phenotyping in Obese Patients with Heart Failure with Preserved Ejection Fraction
Frequency, predictors, and prognosis of ejection fraction improvement in heart failure: an echocardiogram-based registry study